These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8431526)

  • 1. Correlation between the prevalence of gastritis and gastric cancer in Japan.
    Fukao A; Hisamichi S; Ohsato N; Fujino N; Endo N; Iha M
    Cancer Causes Control; 1993 Jan; 4(1):17-20. PubMed ID: 8431526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study.
    Fukao A; Komatsu S; Tsubono Y; Hisamichi S; Ohori H; Kizawa T; Ohsato N; Fujino N; Endo N; Iha M
    Cancer Causes Control; 1993 Jul; 4(4):307-12. PubMed ID: 8347779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
    You WC; Blot WJ; Zhang L; Kneller RW; Li JY; Jin ML; Chang YS; Zeng XR; Zhao L; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):113-7. PubMed ID: 8467245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer.
    Matsukura N; Onda M; Tokunaga A; Fujita I; Okuda T; Mizutani T; Kyono S; Yamashita K
    J Clin Gastroenterol; 1993; 17 Suppl 1():S146-50. PubMed ID: 8283010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O6-methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. The EUROGAST Study Group.
    Carcinogenesis; 1994 Sep; 15(9):1815-20. PubMed ID: 7923573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
    Knight T; Wyatt J; Wilson A; Greaves S; Newell D; Hengels K; Corlett M; Webb P; Forman D; Elder J
    Br J Cancer; 1996 Mar; 73(6):819-24. PubMed ID: 8611388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk.
    Palli D; Decarli A; Cipriani F; Forman D; Amadori D; Avellini C; Giacosa A; Manca P; Russo A; Salkeld RM
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):45-50. PubMed ID: 1845168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zymogenic cell mass and serum pepsinogen I: the cell secretory correlations in patients with gastric intestinal-type cancer of the corpus-fundus].
    Testino G; Perasso A
    Minerva Med; 1992 Sep; 83(9):507-11. PubMed ID: 1436599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pepsinogen].
    Miki K
    Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen A in atrophic chronic gastritis and in gastric cancer: a distinctive difference in behavior?
    Perasso A; Testino G
    J Clin Gastroenterol; 1992 Sep; 15(2):164-6. PubMed ID: 1401833
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.